Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12439/2835
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKamal S.en
dc.contributor.authorSegal J.P.en
dc.date.accessioned2025-01-29T04:21:21Z-
dc.date.available2025-01-29T04:21:21Z-
dc.date.copyright2024-
dc.date.created2024-07-27-
dc.date.issued2024-12-01-
dc.identifier.citationTherapeutic Advances in Gastroenterology. 17(no pagination), 2024. Date of Publication: January-December 2024.-
dc.identifier.issn1756-283X-
dc.identifier.urihttps://hdl.handle.net/20.500.12439/2835-
dc.titleComment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study].-
dc.typeLetter-
dc.description.affiliates(Kamal, Segal) Department of Gastroenterology, Northern Health, 185 C, ooper Street, Epping, Melbourne, VIC 3076, Australia-
dc.description.affiliates(Segal) Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia-
dc.description.affiliates(Segal) Department of Medicine, The University of Melbourne, Parkville, Melbourne, VIC, Australia-
dc.publisher.placeUnited Kingdom-
dc.identifier.doihttps://dx.doi.org/10.1177/17562848241265761-
dc.identifier.journaltitleTherapeutic Advances in Gastroenterology-
dc.type.studyortrialCommentary-
dc.subject.keywordsCrohn disease-
dc.contributor.nhauthorS Kamalen
dc.contributor.nhauthorJ P Segalen
dc.description.nhaffiliation(Kamal, Segal) Department of Gastroenterology, Northern Health, Melbourne, VIC 3076, Australia-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeLetter-
item.cerifentitytypePublications-
Appears in Collections:Articles
Show simple item record

Page view(s)

16
checked on Apr 17, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.